|
SEOUL, South Korea, April 15, 2026 /PRNewswire/ -- ASK Company, the parent company of RIMAN, has entered into a sponsored research agreement with Mitragotri Laboratory at the Harvard John A. Paulson School of Engineering and Applied Sciences to validate the functionality and effectiveness of its proprietary ingredient, Araliadiol, derived from Giant BYoungPool™.
Araliadiol is a novel active compound identified through ASK Company's proprietary extraction and purification technology from Giant BYoungPool™, RIMAN's signature heritage ingredient. It has demonstrated multiple biological benefits even at low concentrations, including anti-inflammatory effects, antioxidant activity through the reduction of reactive oxygen species, and overall skin improvement.
To validate its efficacy, ASK Company has built a collaborative research network with leading Korean institutions. Through joint studies with Sungkyunkwan University and Konkuk University, the company has elucidated its mechanism of action and confirmed strong cell-protective effects and differentiated efficacy. In addition, a synthetic production process for pure Araliadiol has been developed, supporting its scalability and safety as a next-generation cosmetic ingredient.
Building on these results, ASK Company has entered into a sponsored research collaboration with the Mitragotri Lab to advance fundamental understanding of the function and action of Araliadiol. As part of this collaboration, a formal agreement ceremony was held on April 13 at the Harvard Science & Engineering Complex. The event was attended by Samir Mitragotri, the Hiller Professor of Bioengineering at Harvard and Hansjorg Wyss Professor of Biologically Inspired Engineering at the Wyss Institute, Mr. Joonghyun Ahn, Founder & Chairman, and Dr. Jiwon Seo, Researcher of RIMAN/ASK Company, marking the official launch of the sponsored research initiative.
The collaboration will leverage organ-on-a-chip technology, a biomimetic platform that replicates human physiological environments on microchips, enabling understanding of biological responses. Using this model, the research team will evaluate Araliadiol with a focus on skin regeneration and hair growth through follicular cell activation.
Mr. Joonghyun Ahn, Founder & Chairman RIMAN/ASK Company stated, "This research collaboration marks a significant milestone in our R&D journey. We aim to validate the efficacy of Araliadiol and establish it as a functional ingredient in the beauty market."
ASK Company plans to further strengthen the heritage of Giant BYoungPool™ and reinforce its position as a distinctive natural-origin ingredient in the global K-beauty industry.
About RIMAN
Founded in 2018 in South Korea, RIMAN is a global beauty and wellness direct-selling company redefining K-Beauty through heritage ingredients from Jeju Island and cutting-edge innovation. At its Jeju Smart Farm, RIMAN manages every step, from raw material cultivation to product development, including its signature ingredient, Giant BYoungPool™—an advanced Centella Asiatica cultivar granted 20-year Plant Variety Protection by the Korea Forest Service in July 2022 and the U.S. Department of Agriculture (USDA) in September 2025.
SEOUL, South Korea, April 15, 2026 /PRNewswire/ -- ASK Company, the parent company of RIMAN, has entered into a sponsored research agreement with Mitragotri Laboratory at the Harvard John A. Paulson School of Engineering and Applied Sciences to validate the functionality and effectiveness of its proprietary ingredient, Araliadiol, derived from Giant BYoungPool™.
Araliadiol is a novel active compound identified through ASK Company's proprietary extraction and purification technology from Giant BYoungPool™, RIMAN's signature heritage ingredient. It has demonstrated multiple biological benefits even at low concentrations, including anti-inflammatory effects, antioxidant activity through the reduction of reactive oxygen species, and overall skin improvement.
To validate its efficacy, ASK Company has built a collaborative research network with leading Korean institutions. Through joint studies with Sungkyunkwan University and Konkuk University, the company has elucidated its mechanism of action and confirmed strong cell-protective effects and differentiated efficacy. In addition, a synthetic production process for pure Araliadiol has been developed, supporting its scalability and safety as a next-generation cosmetic ingredient.
Building on these results, ASK Company has entered into a sponsored research collaboration with the Mitragotri Lab to advance fundamental understanding of the function and action of Araliadiol. As part of this collaboration, a formal agreement ceremony was held on April 13 at the Harvard Science & Engineering Complex. The event was attended by Samir Mitragotri, the Hiller Professor of Bioengineering at Harvard and Hansjorg Wyss Professor of Biologically Inspired Engineering at the Wyss Institute, Mr. Joonghyun Ahn, Founder & Chairman, and Dr. Jiwon Seo, Researcher of RIMAN/ASK Company, marking the official launch of the sponsored research initiative.
The collaboration will leverage organ-on-a-chip technology, a biomimetic platform that replicates human physiological environments on microchips, enabling understanding of biological responses. Using this model, the research team will evaluate Araliadiol with a focus on skin regeneration and hair growth through follicular cell activation.
Mr. Joonghyun Ahn, Founder & Chairman RIMAN/ASK Company stated, "This research collaboration marks a significant milestone in our R&D journey. We aim to validate the efficacy of Araliadiol and establish it as a functional ingredient in the beauty market."
ASK Company plans to further strengthen the heritage of Giant BYoungPool™ and reinforce its position as a distinctive natural-origin ingredient in the global K-beauty industry.
About RIMAN
Founded in 2018 in South Korea, RIMAN is a global beauty and wellness direct-selling company redefining K-Beauty through heritage ingredients from Jeju Island and cutting-edge innovation. At its Jeju Smart Farm, RIMAN manages every step, from raw material cultivation to product development, including its signature ingredient, Giant BYoungPool™—an advanced Centella Asiatica cultivar granted 20-year Plant Variety Protection by the Korea Forest Service in July 2022 and the U.S. Department of Agriculture (USDA) in September 2025.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
RIMAN's Parent Company Announces Sponsored Research Agreement to Advance Araliadiol Using Organ-on-a-Chip Technology
NEW YORK, April 22, 2026 /PRNewswire/ -- Over the past 28 days, Dimora Medical has seen an average daily increase of over 165% in visitors to its TikTok Shop for its hydrocolloid roll, driven by several factors, with a recent creator video emerging as a key source of visibility and interest. Originally designed as a medical-grade wound dressing, the roll is now gaining wider attention from consumers who value its flexibility, ease of use, and greater value compared with small pre-cut pimple patches.
Unlike individual acne patches, the hydrocolloid roll can be trimmed to the exact size needed, whether for a single blemish, a larger breakout area, or minor wound coverage. It gives users more usable material in one package and is a practical home-care item that can be used to address multiple everyday needs.
Authentic, lifestyle creator content goes viral
The video, posted by the creator @toporganize, starts with her showing Dimora Medical's hydrocolloid roll and exclaiming, "I wish that someone would have put me on to these sooner than last week!" She then describes how the 16-foot-long roll is a much better value than smaller pimple pads, and how it's easy to cut and shape to apply on different parts of her face.
Her practical, real presentation of how to use the roll while emphasizing how the roll aids skin repair for minor facial imperfections has attracted a new group of users to Dimora Medical. The roll itself is hypoallergenic and has passed strict third-party skin irritation and skin sensitivity tests.
Safe, skin-friendly wound and acne recovery
Made of a gentle, non-irritating adhesive, Dimora Medical's hydrocolloid roll is applied directly to the skin. By creating a moist healing environment, it effectively promotes wound recovery and brings a healing efficiency that is 2-3 times higher than other conventional cures.
It also brings visible relief to acne sufferers. Acne pus is actively absorbed, while noticeable redness and swelling are reduced within 8 hours. The hydrocolloid roll effectively addresses multiple acne concerns, including common pimples, papules, and cystic acne.
The medical-grade hydrocolloid roll is FDA certified and was independently tested by STC labs. It passed under the international standard ISO 10993-23 for skin irritation, as determined by intracutaneous reactivity. It also passed the ISO 10993-5 standard for skin sensitivity, as determined by cytotoxicity.
For more information, please visit https://www.dimoramedical.com/.
DimoraMedical:
support@DimoraMedical.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Dimora Medical Goes Viral on TikTok, as Hydrocolloid Roll Finds New Use in Acne Care
